title: Pharmacokinetics and biotransformation of estradiol valerate in ovariectomized women.
abstract: Estradiol valerate is well suited for treatment of the characteristic symptoms accompanying menopause in women. The pharmacokinetics and biotransformation of estradiol valerate were studied in women following intravenous, intramuscular and oral administration. Intravenously given, estradiol valerate is split by enzymatic hydrolysis into 17 beta-estradiol and the fatty acid. The estrogen arising in vivo from the steroid ester is subject to intermediate metabolism. The metabolites are eliminated at a nearly constant rate mainly in urine. The biotransformation of estradiol valerate was not different following intravenous or intramuscular injection. Orally given estradiol valerate is subject to an extensive first pass metabolism. Daily repeated oral administration does not result in accumulation of 17 beta-estradiol and its metabolites.
authors.forename: B
authors.initials: B
authors.lastname: Düsterberg
authors.forename: M
authors.initials: M
authors.lastname: Schmidt-Gollwitzer
authors.forename: M
authors.initials: M
authors.lastname: Hümpel
mesh_terms: D000284:Administration, Oral; D000328:Adult; D001711:Biotransformation; D002369:Castration; D004958:Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood; D004964:Estriol / Q000097:blood; D004966:Estrogens, Conjugated (USP) / Q000097:blood; D004970:Estrone / Q000097:blood; D005260:Female; D006207:Half-Life; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007700:Kinetics; D008593:Menopause; D008875:Middle Aged
chemical_list: D004966:Estrogens, Conjugated (USP); D004970:Estrone; D004958:Estradiol; D004964:Estriol